/
/
/

Krebs Biochemicals & Industries Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
-5%-10%-14%
----37%
--21%-4%-26%
-98%0%0%0%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
KREBSBIO
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,849.9₹447476 Cr3712.0762.82₹11479 Cr
9,602₹254764 Cr87.134.04128.41₹2568 Cr
4,928.5₹189423 Cr86.8516.7297.06₹2163 Cr
1,180.3₹116658 Cr25.859.4262.53₹5040 Cr
1,399₹111484 Cr33.089.7757.87₹3879 Cr
2,026.2₹109943 Cr100.556.829.25₹889 Cr
2,500₹101712 Cr49.7913.7571.08₹1913 Cr
1,200.4₹101005 Cr31.355.3263.99₹4196 Cr
1,716₹99253 Cr26.7317.9596.84₹3505 Cr
2,100.7₹96031 Cr17.3730.95154.35₹5333 Cr
57.77₹124 Cr-1.15-3.56-₹17 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%

Balance Sheet

Consolidated
Standalone
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Trade Payables
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Sep 2014Jun 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008Mar 2007
₹22 Cr₹22 Cr₹22 Cr₹22 Cr₹20 Cr₹18 Cr₹17 Cr₹14 Cr₹14 Cr₹13 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹9 Cr₹9 Cr₹9 Cr₹7 Cr₹7 Cr
₹0₹0₹0₹0₹4 Cr₹8 Cr₹0₹0₹0₹4 Cr₹23 Cr₹0₹0₹0₹1 Cr₹0₹0₹12 Cr₹2 Cr
-₹168 Cr-₹141 Cr-₹121 Cr-₹97 Cr-₹67 Cr-₹51 Cr-₹31 Cr-₹32 Cr-₹12 Cr-₹4 Cr-₹14 Cr-₹6 Cr-₹2 Cr₹14 Cr₹30 Cr₹37 Cr₹43 Cr₹72 Cr₹83 Cr
-₹168 Cr-₹141 Cr-₹121 Cr-₹97 Cr-₹67 Cr-₹51 Cr-₹31 Cr-₹32 Cr-₹12 Cr-₹4 Cr-₹14 Cr-₹6 Cr-₹2 Cr₹14 Cr₹30 Cr₹37 Cr₹43 Cr₹72 Cr₹83 Cr
-₹146 Cr-₹119 Cr-₹99 Cr-₹75 Cr-₹43 Cr-₹25 Cr-₹14 Cr-₹18 Cr₹1 Cr₹13 Cr₹18 Cr₹4 Cr₹8 Cr₹23 Cr₹41 Cr₹46 Cr₹52 Cr₹91 Cr₹91 Cr
₹0₹0₹0₹0₹0₹0₹0₹2 Cr₹5 Cr₹21 Cr₹14 Cr₹15 Cr₹49 Cr₹59 Cr₹65 Cr₹76 Cr₹72 Cr₹72 Cr₹83 Cr
₹161 Cr₹184 Cr₹173 Cr₹133 Cr₹101 Cr₹66 Cr₹50 Cr₹50 Cr₹38 Cr₹4 Cr₹44 Cr₹7 Cr₹8 Cr₹6 Cr₹6 Cr₹11 Cr₹11 Cr₹9 Cr₹5 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0-₹1 Cr-₹1 Cr-₹2 Cr-₹97 L₹93 L₹4 Cr₹13 Cr₹14 Cr₹16 Cr
₹45 Cr₹45 Cr₹45 Cr₹45 Cr₹45 Cr₹45 Cr₹44 Cr₹43 Cr₹43 Cr₹45 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹2 Cr₹4 Cr₹4 Cr₹6 Cr₹6 Cr₹3 Cr₹4 Cr₹3 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹4 Cr₹4 Cr₹3 Cr₹4 Cr₹4 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹0₹0₹0₹0
₹212 Cr₹236 Cr₹225 Cr₹187 Cr₹154 Cr₹116 Cr₹102 Cr₹101 Cr₹89 Cr₹74 Cr₹60 Cr₹23 Cr₹57 Cr₹66 Cr₹73 Cr₹91 Cr₹96 Cr₹95 Cr₹103 Cr
₹18 Cr₹19 Cr₹15 Cr₹38 Cr₹21 Cr₹23 Cr₹21 Cr₹18 Cr₹11 Cr₹12 Cr₹17 Cr₹20 Cr₹20 Cr₹27 Cr₹21 Cr₹16 Cr₹13 Cr₹6 Cr₹9 Cr
₹34 Cr₹32 Cr₹23 Cr₹29 Cr₹16 Cr₹18 Cr₹32 Cr₹23 Cr₹20 Cr₹16 Cr₹12 Cr₹85 Cr₹32 Cr₹16 Cr₹6 Cr₹4 Cr₹10 Cr₹7 Cr₹8 Cr
₹51 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹0₹0₹0₹0₹0₹0₹3 Cr₹19 Cr₹15 Cr₹15 Cr₹0₹0₹0₹0
₹79 L₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹1 Cr₹1 Cr₹87 L₹82 L₹9 L₹2 Cr₹24 L₹16 L₹33 L₹1 Cr₹1 Cr₹1 Cr₹1 Cr
₹104 Cr₹62 Cr₹49 Cr₹78 Cr₹48 Cr₹43 Cr₹55 Cr₹42 Cr₹32 Cr₹30 Cr₹29 Cr₹110 Cr₹71 Cr₹59 Cr₹43 Cr₹21 Cr₹24 Cr₹14 Cr₹18 Cr
₹169 Cr₹178 Cr₹175 Cr₹190 Cr₹159 Cr₹134 Cr₹142 Cr₹126 Cr₹122 Cr₹116 Cr₹107 Cr₹136 Cr₹136 Cr₹148 Cr₹157 Cr₹158 Cr₹172 Cr₹200 Cr₹212 Cr
₹9 Cr₹9 Cr₹6 Cr₹6 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹6 Cr₹4 Cr₹5 Cr₹5 Cr₹11 L₹7 Cr₹3 Cr₹3 Cr₹5 Cr₹7 Cr₹2 Cr
₹212 Cr₹194 Cr₹183 Cr₹143 Cr₹111 Cr₹66 Cr₹53 Cr₹56 Cr₹48 Cr₹31 Cr₹61 Cr₹93 Cr₹93 Cr₹86 Cr₹86 Cr₹87 Cr₹83 Cr₹81 Cr₹87 Cr
₹314 Cr₹312 Cr₹303 Cr₹288 Cr₹261 Cr₹243 Cr₹234 Cr₹230 Cr₹227 Cr₹213 Cr₹167 Cr₹164 Cr₹164 Cr₹164 Cr₹162 Cr₹155 Cr₹167 Cr₹161 Cr₹159 Cr
₹168 Cr₹163 Cr₹156 Cr₹149 Cr₹143 Cr₹138 Cr₹133 Cr₹129 Cr₹124 Cr₹120 Cr₹116 Cr₹114 Cr₹114 Cr₹105 Cr₹96 Cr₹86 Cr₹80 Cr₹70 Cr₹60 Cr
₹146 Cr₹150 Cr₹147 Cr₹139 Cr₹118 Cr₹105 Cr₹101 Cr₹101 Cr₹102 Cr₹93 Cr₹51 Cr₹51 Cr₹51 Cr₹58 Cr₹66 Cr₹69 Cr₹87 Cr₹90 Cr₹99 Cr
₹1 Cr₹16 L₹2 Cr₹7 Cr₹10 Cr₹2 Cr₹2 Cr₹2 Cr₹4 Cr₹11 Cr₹0₹0₹0₹0₹0₹4 Cr₹3 Cr₹6 Cr₹5 Cr
₹10 Cr₹9 Cr₹8 Cr₹7 Cr₹8 Cr₹5 Cr₹6 Cr₹4 Cr₹3 Cr₹3 Cr₹34 Cr₹40 Cr₹40 Cr₹39 Cr₹37 Cr₹0₹0₹0₹0
₹0₹0₹0₹0₹23 L₹21 L₹42 L₹41 L₹20 L₹20 L₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹159 Cr₹161 Cr₹159 Cr₹154 Cr₹138 Cr₹115 Cr₹111 Cr₹109 Cr₹109 Cr₹107 Cr₹92 Cr₹98 Cr₹97 Cr₹105 Cr₹109 Cr₹72 Cr₹91 Cr₹96 Cr₹105 Cr
₹6 Cr₹10 Cr₹12 Cr₹26 Cr₹17 Cr₹15 Cr₹9 Cr₹12 Cr₹5 Cr₹6 Cr₹5 Cr₹31 Cr₹31 Cr₹30 Cr₹29 Cr₹29 Cr₹21 Cr₹48 Cr₹47 Cr
₹5 L₹2 Cr₹53 L₹88 L₹30 L₹20 L₹3 Cr₹32 L₹2 Cr₹3 L₹37 L₹62 L₹92 L₹8 Cr₹13 Cr₹28 Cr₹30 Cr₹26 Cr₹30 Cr
₹14 L₹14 L₹9 L₹10 L₹71 L₹17 L₹17 Cr₹42 L₹12 L₹27 L₹6 Cr₹36 L₹33 L₹43 L₹37 L₹51 L₹42 L₹67 L₹96 L
₹65 L₹54 L₹65 L₹59 L₹47 L₹31 L₹21 L₹33 L₹14 L₹8 L₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹93 L₹0₹0₹0₹0
₹3 Cr₹5 Cr₹3 Cr₹8 Cr₹3 Cr₹3 Cr₹2 Cr₹4 Cr₹6 Cr₹3 Cr₹59 L₹5 Cr₹5 Cr₹3 Cr₹4 Cr₹22 Cr₹25 Cr₹24 Cr₹25 Cr
₹10 Cr₹17 Cr₹16 Cr₹35 Cr₹21 Cr₹19 Cr₹31 Cr₹17 Cr₹13 Cr₹9 Cr₹15 Cr₹39 Cr₹38 Cr₹43 Cr₹48 Cr₹80 Cr₹76 Cr₹99 Cr₹103 Cr
-₹93 Cr-₹44 Cr-₹33 Cr-₹43 Cr-₹27 Cr-₹24 Cr-₹24 Cr-₹25 Cr-₹19 Cr-₹20 Cr-₹14 Cr-₹71 Cr-₹32 Cr-₹16 Cr₹5 Cr₹59 Cr₹52 Cr₹85 Cr₹85 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹5 Cr₹5 Cr₹5 Cr₹5 Cr
₹169 Cr₹178 Cr₹175 Cr₹190 Cr₹159 Cr₹134 Cr₹142 Cr₹126 Cr₹122 Cr₹116 Cr₹107 Cr₹136 Cr₹136 Cr₹148 Cr₹157 Cr₹158 Cr₹172 Cr₹200 Cr₹212 Cr
-₹68-₹55-₹46-₹35-₹24-₹18-₹9-₹13₹1₹7-₹5₹4₹8₹24₹43₹45₹52₹106₹120
-₹68-₹55-₹46-₹35-₹24-₹18-₹9-₹12₹1₹7-₹5₹4₹8₹23₹42₹44₹50₹102₹116

Cash Flow

Consolidated
Standalone
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Sep 2014Jun 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008Mar 2007
-₹27 Cr-₹20 Cr-₹25 Cr-₹45 Cr-₹28 Cr-₹29 Cr-₹20 Cr-₹17 Cr-₹16 Cr-₹17 Cr-₹11 Cr-₹4 Cr-₹16 Cr-₹19 Cr-₹10 Cr-₹15 Cr-₹44 Cr-₹11 Cr-₹9 Cr
₹12 Cr₹12 Cr₹10 Cr₹11 Cr₹12 Cr₹9 Cr₹10 Cr₹6 Cr₹11 Cr₹3 Cr₹9 Cr₹22 L₹3 Cr₹16 Cr₹10 Cr₹13 Cr₹16 Cr₹21 Cr₹21 Cr
₹7 Cr₹10 Cr-₹10 Cr₹16 Cr₹2 Cr-₹16 Cr₹14 Cr₹9 Cr-₹2 Cr-₹1 Cr-₹39 Cr₹55 Cr₹12 Cr₹20 Cr₹2 Cr-₹7 Cr₹33 Cr-₹2 Cr-₹11 Cr
-₹8 Cr₹2 Cr-₹25 Cr-₹17 Cr-₹15 Cr-₹35 Cr₹4 Cr-₹1 Cr-₹8 Cr-₹15 Cr-₹41 Cr₹51 Cr-₹81 L₹16 Cr₹2 Cr-₹9 Cr₹4 Cr₹8 Cr₹1 Cr
-₹8 Cr₹2 Cr-₹25 Cr-₹17 Cr-₹15 Cr-₹35 Cr₹4 Cr-₹6 Cr-₹11 Cr-₹15 Cr-₹45 Cr₹49 Cr-₹2 Cr₹7 Cr-₹5 Cr-₹16 Cr-₹4 Cr-₹1 Cr-₹9 Cr
-₹5 Cr-₹8 Cr-₹13 Cr-₹23 Cr-₹23 Cr-₹10 Cr-₹4 Cr-₹3 Cr-₹5 Cr-₹4 Cr-₹3 Cr₹7 L₹6 Cr-₹1 Cr₹4 Cr₹12 Cr-₹4 Cr-₹1 Cr₹17 Cr
₹13 Cr₹6 Cr₹37 Cr₹40 Cr₹38 Cr₹29 Cr₹17 Cr₹9 Cr₹16 Cr₹13 Cr₹54 Cr-₹49 Cr-₹4 Cr-₹6 Cr₹72 L₹4 Cr₹7 Cr₹2 Cr-₹8 Cr
₹42,000₹5 L-₹1 L-₹61 L₹54 L-₹17 Cr₹17 Cr₹30 L-₹15 L-₹6 Cr₹6 Cr₹3 L-₹10 L₹7 L-₹14 L₹9 L-₹25 L-₹28 L-₹25 L
₹14 L₹9 L₹10 L₹71 L₹17 L₹17 Cr₹42 L₹12 L₹27 L₹6 Cr₹36 L₹33 L₹43 L₹37 L₹51 L₹42 L₹67 L₹96 L₹1 Cr
₹14 L₹14 L₹9 L₹10 L₹71 L₹17 L₹17 Cr₹42 L₹12 L₹27 L₹6 Cr₹36 L₹33 L₹43 L₹37 L₹51 L₹42 L₹67 L₹96 L

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)57.54
Volume (₹)3,409.00
High (₹)57.89
Upper Circuit69.04
Low (₹)55.51
Lower Circuit46.04
Prev Close57.54
52W High (₹)80.00
Price57.77
52W Low (₹)38.33

Share Market Cap & Key Ratios Overview

M.Cap (₹)124.06 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity-1.45
Price to Book-0.98
Book Value-67.83
EPS (TTM)-6.54
Face Value10.00
ROE (%)0.00

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
KREBSBIONSE
LTP
1W Low
1W High
Market cap (₹)
1849.9+12.6 (0.69%)
1832.20
1891.50
4,47,476Cr
9602+227 (2.42%)
9312.50
9740
2,54,764Cr
4928.5+88.5 (1.83%)
4848.50
5010
1,89,423Cr
1180.3+20.3 (1.75%)
1152.10
1190.60
1,16,658Cr
1399+4.5 (0.32%)
1364.50
1419
1,11,484Cr
2026.2+72.2 (3.69%)
1963.80
2055.30
1,09,943Cr
2500+199.3 (8.66%)
2303
2504.30
1,01,712Cr
1200.4+15.4 (1.30%)
1185
1222
1,01,005Cr
1716-18 (-1.04%)
1689.30
1740
99,253Cr
2100.7+17.7 (0.85%)
2080
2135
96,031Cr
57.77+0.46 (0.80%)
55.40
59.60
124Cr

Krebs Biochemicals & Industries Ltd Annual Results Key Takeaways

Basis: Consolidated annual results.

Krebs Biochemicals & Industries Ltd Quaterly Results Key Takeaways